Tr‐KIT Downstream Regulation by YY1 and NFYA Transcription Factors Knockdown in Prostate Cancer Cells
- 26 July 2025
- journal article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 64 (7) , e70063
Abstract
Background: Prostate cancer is a common and deadly cancer among men and has been the subject of many patients in its diagnosis and treatment. Imatinib, a tyrosine kinase inhibitor, can slow tumor formation by targeting c‐KIT, an oncogenic receptor tyrosine kinase protein over‐expressed in PCa cases. However, Imatinib has no effect on tr‐KIT, a truncated form of c‐KIT, which is over‐expressed in PCa and is associated with neoplastic transformation. In this study, it is aimed to answer whether the anti‐proliferative efficacy of Imatinib on PCa cells could be enhanced by inhibition of tr‐KIT specific transcription factors.Methods and Results: For this purpose, gene expression analysis and cell viability assays were performed in LNCaP prostate cancer cells to investigate the effects of inhibition of transcription factors controlling tr‐KIT expression (YY1 and NFYA) in combination with Imatinib administration. As a result, YY1 and NFYA were identified as tr‐KIT‐specific transcription factors and found that their knockdown increased the effectiveness of Imatinib mesylate treatment on LNCaP cells. The study also analyzed the gene expression changes of c‐KIT, FYN, PLCγ1, and SAM68 genes and found that SAM68 expression decreased with NFYA and YY1 knockdown, suggesting the existence of other unknown mediators in the tr‐KIT pathway.Conclusions: All in all, this study demonstrates that tr‐KIT may be a potential pharmacological target for prostate cancer treatment and that inhibition of the transcription factors YY1 and NFYA may enhance the efficacy of Imatinib. SAM68 was found to be the most affected protein by the treatments, guiding future research.Keywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (119Z574)
This publication has 47 references indexed in Scilit:
- The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancerJournal of Cell Communication and Signaling, 2017
- Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biologyCancer and Metastasis Reviews, 2016
- The SCF/c-KIT system in the male: Survival strategies in fertility and cancerMolecular Reproduction and Development, 2014
- The association of the expression of miR-122-5p and its target ADAM10 with human breast cancerMolecular Biology Reports, 2014
- Expression patterns of miR-221 and its target Caspase-3 in different cancer cell linesMolecular Biology Reports, 2014
- Regulation of cell proliferation through a KIT‐mediated mechanism in benign prostatic hyperplasiaThe Prostate, 2012
- Sam68 up‐regulation correlates with, and its down‐regulation inhibits, proliferation and tumourigenicity of breast cancer cellsThe Journal of Pathology, 2010
- Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapyCancer Chemotherapy and Pharmacology, 2010
- The RNA‐binding and adaptor protein Sam68 modulates signal‐dependent splicing and transcriptional activity of the androgen receptorThe Journal of Pathology, 2008
- Ectopic expression of KitD814Y in spermatids of transgenic mice, interferes with sperm morphogenesisDevelopmental Dynamics, 2005